Evidence map›Paper›PMID 15338191›Full record

ReviewSpringer seminars in immunopathology2005

Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances.

Gwendalyn J Randolph, Guzman Sanchez-Schmitz, Veronique Angeli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Springer seminars in immunopathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 127 citations in OpenAlex.

  1. ABCC1 protects skin dendritic cells from FITC-induced toxicity by efflux and extracellular glutathione buffering.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. In Sickness and in Health: The Immunological Roles of the Lymphatic System.International journal of molecular sciences · 2021
    Review
  6. Regulation of the Migration of Distinct Dendritic Cell Subsets.Frontiers in cell and developmental biology · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Distinct features of dendritic cell-based immunotherapy as cancer vaccines.Clinical and experimental vaccine research · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gwendalyn J RandolphDepartment of Gene and Cell Medicine, Mt. Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA. Gwendalyn.Randolph@mssm.edu
Guzman Sanchez-Schmitz
Veronique Angeli
Icahn School of Medicine at Mount Sinai · USMount Sinai Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cell (DC) migration from peripheral organs to lymph nodes plays a key role in initiating immune responses, whether migratory DCs bring antigen in tow to lymph nodes or position themselves to capture antigen that drains into the lymph node. CCR7 prominently controls DC migration into afferent lymphatic vessels and the positioning of DCs within the lymph node. Expression of CCR7 is not sufficient for function, as its function is positively regulated by a variety of other extracellular triggers. At least one of these triggers, synthesis and secretion of PGE(2), is brought on by the activation of p38 MAP kinase. The MAP kinase pathway has been well studied in DCs and exhibits a complex regulatory role in which the activation of different MAP kinase members leads to biologically distinct outcomes that are dependent upon stage of differentiation at the time of activation as well as the duration of signaling. Almost all of our knowledge of how DCs mature and ultimately mobilize to lymph nodes comes from studies in which DC migration is probed in the context of immune activation and priming. A reasonable body of evidence has gathered to suggest that many molecular events important for DC migration in this context do not affect accumulation of DCs in lymph nodes in the steady state, but mediators that interface with the signaling adaptor DAP-12 may play key roles in the steady state. It may thus become possible to devise approaches to modulate DC mobilization in the context of inflammation without affecting the traffic of DCs during more quiescent conditions. Considering the finely tuned regulation of DC maturation, migration, and cytokine production, with the realization that these phenotypes can be mutually exclusive, manipulation of DC migration in the clinic will be a challenging, albeit feasible, task.

Indexed as

Adaptor Proteins, Signal TransducingADP-ribosyl CyclaseADP-ribosyl Cyclase 1AnimalsAntigen PresentationAntigens, CDCell MovementCytokinesDendritic CellsDinoprostoneHumansLeukotriene C4Lymphatic SystemMacrophagesMAP Kinase Signaling SystemMembrane GlycoproteinsAdaptor Proteins, Signal TransducingADP-ribosyl CyclaseADP-ribosyl Cyclase 1Antigens, CDCCR7 protein, humanCcr7 protein, mouseCD38 protein, humanCd38 protein, mouseCytokinesDinoprostoneLeukotriene C4Membrane GlycoproteinsNF-kappa BReceptors, CCR7Receptors, ChemokineTyrobp protein, mouse

Identifiers

PMID15338191
OpenAlexW2084948863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.